Fisher and Paykel has announced its financial results for the business year ending on March 31st 2013, during which it achieved a record performance. Read More
Covidien has announced the results from a clinical trial showing the benefits its Barrx RF Ablation System can provide in the treatment of Barrett's oesophagus. Read More
Adelphi Communications has announced a major new brand update that will allow it to better serve the needs of pharmaceutical, diagnostics and device industry clients. Read More
Gilead Sciences has announced that the European Medicines Agency has accepted its new chronic hepatitis C virus (HCV) therapy sofosbuvir for review. Read More
Bayer HealthCare has announced the appointment of Johannes Schubmehl as its new chief information officer (CIO), effective as of the beginning of this month. Read More
Boehringer Ingelheim has honoured the winner of the Healthcare Innovation World Cup, an international diabetes innovation challenge it helped to fund. Read More
AbbVie has announced the launch of a phase III trial of the investigational compound atrasentan to assess its impact on renal outcomes in patients with diabetic nephropathy. Read More
Actavis has entered into a definitive agreement to acquire fellow healthcare company Warner Chilcott in a stock-for-stock transaction valued at around $8.5 billion (5.64 billion pounds). Read More
The British Veterinary Association (BVA) has backed a recent report from the Environment, Food and Rural Affairs Select Committee calling for the introduction of dog control notices (DCNs) across the ... Read More
A new study conducted in Germany has established a link between the presence of posttraumatic stress disorder (PTSD) and an increased risk of developing type 2 diabetes. Read More
Thermo Fisher Scientific has announced the launch of a new small benchtop centrifuge, which aims to deliver high capacity and reliability in a compact design. Read More
Representatives from the Department of Health have addressed the global health community to call for unified action against the "catastrophic threat" posed by antimicrobial resistance. Read More
Bayer HealthCare has announced interim results from a long-term extension study of the drug riociguat that demonstrates the prolonged benefits it can offer to pulmonary arterial hypertension patients. Read More
AbbVie is expanding their collaborative research with Galapagos into a promising new drug to assess whether the compound can aid Crohn's disease sufferers. Read More
